autoimmune disease

Merck bryter med Aqilion

Aqilion har avslutat licens- och samarbetsavtalet med Merck för den gemensamma utvecklingen av TAK1-programmet, med sikte på kronisk inflammation....

Intervju

Aqilions nya program ska bli Best-in-Class

Aqilion utvecklar behandlingar för sjukdomar orsakade av kronisk...

BioStock TV

Intervju

BioStock’s article series on autoimmune disease: Finding the Common Denominator

BioStock’s article series on autoimmune disease has so...

BioStock’s article series on autoimmune disease: Drug Development for RA and MS

Therapies for autoimmune diseases are available but do...

BioStock’s article series on autoimmune disease: The Science

Little is known about the exact causes of...

BioStock’s article series on autoimmune disease: The Patients

Autoimmune diseases are on the rise, and no...